Video
Innovations in Dermatology: Brodalumab for Plaque Psoriasis
In February 2017, the US Food and Drug Administration approved injectable brodalumab (210 mg) to treat patients with moderate to severe plaque...
Lawrence J. Green
In February 2017, the US Food and Drug Administration approved injectable brodalumab (210 mg) to treat patients with moderate to severe plaque...